Análisis
Análisis en profundidad de mercados farmacéuticos, cadenas de suministro, tecnología y regulación
#digital health ×
Análisis
21 sept 2026•1 min de lectura
BaroPharm Submits Securities Filing, Begins KOSDAQ IPO Process
BaroPharm filed a securities report with the Financial Services Commission and announced a public offering of 1.78 million shares, targeting a 16,400‑22,200 KRW price range, aiming for a KOSDAQ listing this year.
Análisis
16 sept 2026•1 min de lectura
Sky Labs Lists on KOSDAQ, Plans Expansion of Cuffless Blood Pressure Platform
Sky Labs has debuted on KOSDAQ, aiming to grow its ring‑type cuffless blood‑pressure monitor domestically and abroad while targeting a broader multi‑bio‑signal medical data platform.
Análisis
30 ago 2026•1 min de lectura
BaroPharm Announces 'Baroland' Promotion for Pharmacies, 5th Anniversary
BaroPharm marks its 5‑year service anniversary by running a July‑long “Baroland” promotion for pharmacy members, offering access to platform features and expressing gratitude.